Brind.

Morgan Stanley downgraded Novo Nordisk stock amid growing geopolitical market worries.

5 reports, 2 independent Updated Sep 21

Gone quiet

Reports: 5
Developments: 1
Repetition: 80%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Morgan Stanley downgraded Novo Nordisk stock amid growing geopolitical market worries.

Who's involved

What this event is mainly about

Morgan Stanley Novo Nordisk

Keep exploring

The entities involved

Morgan Stanley
U.S. investment bank
- Morgan Stanley and Citigroup cut AutoNation's rating and price objective on November 6, 2026.08:34
- Bank of America and Morgan Stanley lowered their price targets for Allegion stock on August 17, 2026.08:32
Novo Nordisk
Danish pharmaceutical company
- Denver hosts the annual MASH meeting, featuring presentations from Novo Nordisk and Gilead Sciences on new therapies.Thu 04:52
- Novo Nordisk's repurchase program is operating under the regulations of the European Union.Tue 16:52

Related events

Berenberg Bank reissued a neutral rating on Novo Nordisk shares today.Oct 20
Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.Oct 23

Coverage

Newest first; wire copies grouped

Sep 20insidermonkey.com
Sep 13aol.com
Sep 11aol.com

2 more outlets ran the same wire story

Sep 21foreignpolicyjournal.com
Sep 20yahoo.com